Delivery Order SPE2DB22D3301-SPE2DB25FY8QF
Award Date 7/31/25
Potential Completion Date 8/21/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $12,365.38 to AmerisourceBergen Drug Corp for the supply of Alunbrig (alectinib) 180 mg tablets in a quantity of 30s. This contract, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this requirement through...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 30, 2025, provides for the supply of Alunbrig 180 mg tablets (30-count) to support federal medical procurement needs. The contract is valued at $12,365.38 under a firm fixed-price arrangement with an ultimate completion date of August 20, 2025. The Defense Logistics Agency (DLA) serves as the funding federal agency. This award represents a non-set-aside, competitively awarded delivery order and does not involve a set-aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the medication Alunbrig 180 mg tablet in quantities of 30, with a total ceiling value of $12,365.38. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Alunbrig in various dosages. The $11,987.90 firm fixed-price contract has a period of performance through December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,365.38 firm fixed-price delivery order covers the supply of ALUNBRIG 180 MG TABLET 30S, a pharmaceutical product, with a period of performance through March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a prescription oncology medication used in cancer treatment. The contract, awarded on July 31, 2025, with an ultimate completion date of August 21, 2025, utilizes firm fixed price pricing with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tagrisso 80 mg, a targeted cancer therapy medication. The contract represents a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $16,666.36 to AmerisourceBergen Drug Corp for 500 mg vials of Alimta, a chemotherapy medication commonly used in cancer treatment. This firm fixed price, non-set-aside contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $135,070.25 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...